Cargando...
Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
The aim of this study was to assess the clinical evidence for platinum-Taxol non-cross-resistance in patients with epithelial ovarian cancer. Unlike other studies, only patients who had demonstrably progressive disease on platinum therapy were analysed. Patients received 135-200 mg m-2 of Taxol over...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2033816/ https://ncbi.nlm.nih.gov/pubmed/7779729 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|